Dial Corp. warning letter
This article was originally published in The Rose Sheet
Firm receives Dec. 29 FDA warning letter stating that an inspection of Dial's Memphis manufacturing site revealed "incomplete batch records, inadequate labeling control, inadequate component control procedures, failure to conduct annual product reviews and incomplete Standard Operating Procedures," causing the company's anti-bacterial soap and antiperspirant products to be adulterated. Dial's Memphis facility makes institutional soaps and personal care and toiletry products. Dial says it has made the changes necessary to bring the firm into compliance and has sent a reply to that effect to FDA
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review